A Clinical Trial Evaluating the Efficacy and Safety of HSK21542 in Patients with Chronic Kidney Disease-Associated Pruritus

NCT05135390 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

545

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Hemodialysis Patients with Moderate-to-Severe Pruritus

Interventions

DRUG: HSK21542
DRUG: Placebo

Sponsor

Haisco Pharmaceutical Group Co., Ltd.